Growth Metrics

Cogent Biosciences (COGT) Other Working Capital Changes (2017 - 2026)

Cogent Biosciences' Other Working Capital Changes history spans 10 years, with the latest figure at -$422000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes rose 80.57% to -$422000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2026, down 9.95% year-over-year, with the annual reading at $195000.0 for FY2025, 95.5% down from the prior year.
  • Other Working Capital Changes came in at -$422000.0 for Q1 2026, down from $3.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $4.3 million in Q4 2024 to a low of -$11.8 million in Q4 2022.
  • The 5-year median for Other Working Capital Changes is $2000.0 (2024), against an average of -$232764.7.
  • Year-over-year, Other Working Capital Changes surged 3248.48% in 2022 and then crashed 108700.0% in 2025.
  • Cogent Biosciences' Other Working Capital Changes stood at -$11.8 million in 2022, then soared by 84.33% to -$1.9 million in 2023, then surged by 334.04% to $4.3 million in 2024, then decreased by 25.3% to $3.2 million in 2025, then plummeted by 113.04% to -$422000.0 in 2026.
  • Per Business Quant, the three most recent readings for COGT's Other Working Capital Changes are -$422000.0 (Q1 2026), $3.2 million (Q4 2025), and -$806000.0 (Q3 2025).